Farms.com Home   News

Early Lessons from Ridgetown’s Long-term Cover Crop Trial for Field Crops

Dr. Dave Hooker and his colleagues have been curious about the value of integrating cover crops into a farming operation in the long term. These questions have remained unanswered by numerous short-term trials they had been conducting, which led them to establish a new trial. As it can take time for a cropping system to equilibrate, this long-term cover crop trial was developed with the hope of uncovering the answers to the questions they had, as well as the questions yet to be asked. Two trial sites have been established in Southern Ontario to capture two different regional environments. The Ridgetown trial represents the deep southwest while the trial at the Elora Research Station represents a shorter growing season. At each location, two primary cropping systems are being investigated, with a specific focus on the response of these systems to a range of cover crop intensities.

Click here to see more...

Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.